Tumor Treating Fields (TTFields) therapy is a relatively innovative treatment approach for cancer, including mesothelioma. Mesothelioma is a rare and aggressive cancer that primarily affects the lining of the lungs (pleural mesothelioma) but can also occur in the lining of the abdomen (peritoneal mesothelioma) or heart (pericardial mesothelioma). It’s often caused by exposure to asbestos.
TTFields therapy involves the use of low-intensity, alternating electric fields that are applied to the body using a medical device. These fields disrupt the division process of cancer cells, thereby potentially slowing or stopping tumor growth.
In the context of mesothelioma, clinical studies have been conducted to evaluate the effectiveness of TTFields therapy in combination with standard treatments like chemotherapy. Some research and clinical trials have shown promising results in terms of extending survival rates and improving quality of life for mesothelioma patients when TTFields therapy is used in conjunction with chemotherapy.
However, like any treatment, TTFields therapy has its own set of considerations and potential side effects. Patients considering this therapy should discuss its potential benefits and risks with their healthcare provider to determine if it’s a suitable option for their specific condition and overall health.
As of my last update in January 2022, research into TTFields therapy for mesothelioma was ongoing, and there might have been new developments or findings in this field since then. It’s essential to consult with medical professionals or access updated resources for the most current information regarding TTFields therapy for mesothelioma.